Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence for …
… patients with and without type 2 diabetes mellitus (T2DM) are … 5 Two trials in patients with T2DM and high CV risk have … , bromocriptine, miglitol, nateglinide, and repaglinide). New users …..... Read More